Impact of the SARS-CoV-2 Pandemic on the Prevalence and Incidence of Enteric Protozoa in a Spanish Tertiary-Care Hospital and a Referral Center for Tropical Diseases, 2019–2023

Objetive: The aim of this study was to describe the impact of non-pharmaceutical interventions (NPIs) against SARS-CoV-2 in patients with symptoms of enteric protozoa (EP), including <i>Blastocystis</i> spp., <i>Dientamoeba fragilis</i>, <i>Giardia lamblia</i>, <i>Cryptosporidium</i> spp., <i>Entamo...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Alfredo Maldonado-Barrueco, Fernando de la Calle-Prieto, Marta Díaz-Menéndez, Marta Arsuaga, Julio García-Rodríguez, Guillermo Ruiz-Carrascoso
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-03-01
Serie:	Medical Sciences
Soggetti:	parasite protozoa gastroenteritis <i>Blastocystis</i> <i>Dientamoeba fragilis</i> <i>Cryptosporidium</i>
Accesso online:	https://www.mdpi.com/2076-3271/13/1/23
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!